You have 9 free searches left this month | for more free features.

Fostamatinib

Showing 1 - 25 of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • Fostamatinib
  • (no location specified)
Jan 12, 2023

Fostamatinib in Patients With ITP. FOSTASUR Study

Completed
  • Primary Immune Thrombocytopenia
  • Fostamatinib
  • Cadiz, Cádiz, Spain
  • +13 more
Oct 3, 2023

Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting
  • Sickle Cell Disease
  • +5 more
  • Fostamatinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2023

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Hematological Malignancies Trial in Durham (fostamatinib)

Active, not recruiting
  • Hematological Malignancies
  • fostamatinib
  • Durham, North Carolina
    Duke University of Medicine
Jul 14, 2022

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Immune Mediated Anemia
  • +2 more
  • fostamatinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Ovarian Cancer Trial in Washington, Baltimore, Philadelphia (Fostamatinib and Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Fostamatinib and Paclitaxel
  • Washington, District of Columbia
  • +2 more
Aug 10, 2022

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Immune Mediated Anemia
  • +2 more
  • fostamatinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Hidradenitis Suppurativa Trial in Sydney (Fostamatinib)

Recruiting
  • Hidradenitis Suppurativa
  • Fostamatinib
  • Sydney, New South Wales, Australia
    Holdsworth House Medical Practice
Mar 15, 2022

Coronavirus Disease 2019 Trial in Bethesda, Falls Church (Placebo, fostamatinib)

Completed
  • Coronavirus Disease 2019
  • Placebo
  • fostamatinib
  • Bethesda, Maryland
  • +1 more
Feb 28, 2022

Renal Transplant Rejection Trial in London (Fostamatinib)

Recruiting
  • Renal Transplant Rejection
  • Fostamatinib
  • London, United Kingdom
    Imperial College NHS Healthcare Trust
Oct 1, 2021

Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

Recruiting
  • Refractory Chronic Myelomonocytic Leukemia
  • Refractory Myelodysplastic Syndrome
  • Fostamatinib
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2021

Covid19, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia Trial in Worldwide (Fostamatinib, Placebo)

Active, not recruiting
  • Covid19
  • +5 more
  • Fostamatinib
  • Placebo
  • Orange, California
  • +46 more
Aug 9, 2022

Adult Immune Thrombocytopenia and Insufficient Response toPrior

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Fostamatinib
  • Springfield, Illinois
  • +7 more
Jul 13, 2021

Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)

Enrolling by invitation
  • Warm Antibody Autoimmune Hemolytic Anemia
  • Fostamatinib disodium
  • Los Angeles, California
  • +36 more
Mar 2, 2022

Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)

Completed
  • Warm Antibody Autoimmune Hemolytic Anemia
  • Fostamatinib 150 mg bid
  • Gilbert, Arizona
  • +35 more
Jul 19, 2021

COVID-19, SARS-CoV2 Infection, Coronavirus Infection Trial in Worldwide (Fostamatinib, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Fostamatinib
  • Placebo
  • Porto Alegre, Brazil
  • +20 more
Jan 6, 2023

Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium, Placebo)

Active, not recruiting
  • Warm Antibody Autoimmune Hemolytic Anemia
  • Fostamatinib disodium
  • Placebo
  • Gilbert, Arizona
  • +101 more
Nov 24, 2021

Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib Disodium)

Completed
  • Immune Thrombocytopenic Purpura
  • Fostamatinib Disodium
  • Tucson, Arizona
  • +54 more
May 21, 2021

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

IGA Nephropathy Trial in Worldwide (Fostamatinib 150 mg, Fostamatinib 100 mg, Placebo)

Completed
  • IGA Nephropathy
  • Fostamatinib 150 mg
  • +2 more
  • Palo Alto, California
  • +19 more
Jun 10, 2019

Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib Disodium, Placebo)

Completed
  • Immune Thrombocytopenic Purpura
  • Fostamatinib Disodium
  • Placebo
  • Nyack, New York
  • +34 more
Jan 24, 2019

Immune Thrombocytopenic Purpura Trial (Fostamatinib disodium 100 mg, Fostamatinib disodium 150 mg)

No longer available
  • Immune Thrombocytopenic Purpura
  • Fostamatinib disodium 100 mg
  • Fostamatinib disodium 150 mg
  • (no location specified)
Jul 30, 2018

Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib disodium, Placebo)

Completed
  • Immune Thrombocytopenic Purpura
  • Fostamatinib disodium
  • Placebo
  • Tucson, Arizona
  • +51 more
Jan 24, 2019

Lymphoma Trial in United States (fostamatinib)

Completed
  • Lymphoma
  • fostamatinib
  • Los Angeles, California
  • +10 more
Aug 9, 2016